Latest news with #DepartmentofUrology
Time of India
11-07-2025
- Health
- Time of India
PGI performs India's first robot-assisted reverse vasectomy
Chandigarh: In a landmark advancement in urological surgery and male infertility treatment , the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, has successfully performed India's first robot-assisted vasovasostomy - a sophisticated procedure to reverse vasectomy - using cutting-edge robotic technology. The breakthrough surgery was performed on July 9, 2025, by a skilled team led by Dr Aditya Prakash Sharma, Dr Girdhar Bora, both Additional Professors, and Prof Ravi Mohan from the Department of Urology. This pioneering intervention replaces the traditional microscope-based technique with the precision of robotic surgery, marking a major leap forward in reproductive microsurgery in India. The patient, a 43-year-old male presenting with secondary infertility following a vasectomy, underwent the procedure using the da Vinci Surgical System . He was discharged the very next day, signaling a swift and successful recovery. Vasovasostomy, commonly known as vasectomy reversal, is a highly intricate microsurgical operation that involves reconnecting the severed ends of the vas deferens to restore the passage of sperm and enable natural conception. Traditionally dependent on high-powered microscopes, the PGIMER team broke new ground by harnessing robotic assistance - offering three-dimensional magnified visualization, enhanced precision, and superior suturing stability. "This innovation reflects PGIMER's unwavering commitment to integrating next-generation technology into patient care," said Dr Aditya Prakash Sharma, the lead surgeon. "Robot-assisted vasovasostomy not only improves accuracy but also reduces surgeon fatigue and eliminates tremor - allowing the use of ultra-fine sutures, even thinner than a strand of human hair. It opens a new horizon for couples desiring natural conception post-vasectomy." Echoing this sentiment, Prof Ravi Mohan highlighted the broader implications: "This successful procedure showcases the versatility of robotic platforms beyond their conventional use in cancer and reconstructive surgeries. It paves the way for expanded applications in andrology and microsurgery." With this surgical first, India joins an elite global league of centres equipped to offer robot-assisted vasovasostomy. PGIMER plans to publish the results in peer-reviewed journals to encourage larger clinical adoption across India and beyond. The team credited the vision and support of Prof Uttam Mete, Head of the Urology Department, and Prof Vivek Lal, director of PGIMER, for enabling such high-precision innovations. Their guidance, they said, played a vital role in turning this milestone into a reality. This achievement not only reinforces PGIMER's reputation as a centre of excellence but also signals a promising future for male infertility treatment in India, said Lal. Chandigarh: In a landmark advancement in urological surgery and male infertility treatment, the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, has successfully performed India's first robot-assisted vasovasostomy - a sophisticated procedure to reverse vasectomy - using cutting-edge robotic technology. The breakthrough surgery was performed on July 9, 2025, by a skilled team led by Dr Aditya Prakash Sharma, Dr Girdhar Bora, both Additional Professors, and Prof Ravi Mohan from the Department of Urology. This pioneering intervention replaces the traditional microscope-based technique with the precision of robotic surgery, marking a major leap forward in reproductive microsurgery in India. The patient, a 43-year-old male presenting with secondary infertility following a vasectomy, underwent the procedure using the da Vinci Surgical System. He was discharged the very next day, signaling a swift and successful recovery. Vasovasostomy, commonly known as vasectomy reversal, is a highly intricate microsurgical operation that involves reconnecting the severed ends of the vas deferens to restore the passage of sperm and enable natural conception. Traditionally dependent on high-powered microscopes, the PGIMER team broke new ground by harnessing robotic assistance - offering three-dimensional magnified visualization, enhanced precision, and superior suturing stability. "This innovation reflects PGIMER's unwavering commitment to integrating next-generation technology into patient care," said Dr Aditya Prakash Sharma, the lead surgeon. "Robot-assisted vasovasostomy not only improves accuracy but also reduces surgeon fatigue and eliminates tremor - allowing the use of ultra-fine sutures, even thinner than a strand of human hair. It opens a new horizon for couples desiring natural conception post-vasectomy." Echoing this sentiment, Prof Ravi Mohan highlighted the broader implications: "This successful procedure showcases the versatility of robotic platforms beyond their conventional use in cancer and reconstructive surgeries. It paves the way for expanded applications in andrology and microsurgery." With this surgical first, India joins an elite global league of centres equipped to offer robot-assisted vasovasostomy. PGIMER plans to publish the results in peer-reviewed journals to encourage larger clinical adoption across India and beyond. The team credited the vision and support of Prof Uttam Mete, Head of the Urology Department, and Prof Vivek Lal, director of PGIMER, for enabling such high-precision innovations. Their guidance, they said, played a vital role in turning this milestone into a reality. This achievement not only reinforces PGIMER's reputation as a centre of excellence but also signals a promising future for male infertility treatment in India, said Lal.
Time of India
10-07-2025
- Health
- Time of India
PGI performs India's first robot-assisted reverse vasectomy
Chandigarh: In a landmark advancement in urological surgery and male infertility treatment, the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, has successfully performed India's first robot-assisted vasovasostomy — a sophisticated procedure to reverse vasectomy — using cutting-edge robotic technology. Tired of too many ads? go ad free now The breakthrough surgery was performed on July 9, 2025, by a skilled team led by Dr Aditya Prakash Sharma, Dr Girdhar Bora, both Additional Professors, and Prof Ravi Mohan from the Department of Urology. This pioneering intervention replaces the traditional microscope-based technique with the precision of robotic surgery, marking a major leap forward in reproductive microsurgery in India. The patient, a 43-year-old male presenting with secondary infertility following a vasectomy, underwent the procedure using the da Vinci Surgical System. He was discharged the very next day, signaling a swift and successful recovery. Vasovasostomy, commonly known as vasectomy reversal, is a highly intricate microsurgical operation that involves reconnecting the severed ends of the vas deferens to restore the passage of sperm and enable natural conception. Traditionally dependent on high-powered microscopes, the PGIMER team broke new ground by harnessing robotic assistance — offering three-dimensional magnified visualization, enhanced precision, and superior suturing stability. "This innovation reflects PGIMER's unwavering commitment to integrating next-generation technology into patient care," said Dr Aditya Prakash Sharma, the lead surgeon. "Robot-assisted vasovasostomy not only improves accuracy but also reduces surgeon fatigue and eliminates tremor — allowing the use of ultra-fine sutures, even thinner than a strand of human hair. It opens a new horizon for couples desiring natural conception post-vasectomy. Tired of too many ads? go ad free now " Echoing this sentiment, Prof Ravi Mohan highlighted the broader implications: "This successful procedure showcases the versatility of robotic platforms beyond their conventional use in cancer and reconstructive surgeries. It paves the way for expanded applications in andrology and microsurgery." With this surgical first, India joins an elite global league of centres equipped to offer robot-assisted vasovasostomy. PGIMER plans to publish the results in peer-reviewed journals to encourage larger clinical adoption across India and beyond. The team credited the vision and support of Prof Uttam Mete, Head of the Urology Department, and Prof Vivek Lal, director of PGIMER, for enabling such high-precision innovations. Their guidance, they said, played a vital role in turning this milestone into a reality. This achievement not only reinforces PGIMER's reputation as a centre of excellence but also signals a promising future for male infertility treatment in India, said Lal.
Time of India
09-07-2025
- Health
- Time of India
AIIMS Jodhpur Hosts RUFCON 2025
Jodhpur: The Department of Urology at AIIMS Jodhpur , in collaboration with the Royal Urology Society (RUS), hosted the 7th edition of RUFCON 2025 , the annual conference of the Robotic Urology Forum . The national-level event convened urologists and healthcare professionals from across India to discuss recent developments in robotic and AI-enabled urologic surgery . Themed 'Advancing Precision in Urologic Surgery through Robotics and AI,' the conference featured over 25 live and semi-live surgeries, alongside expert panels and interactive sessions. Key procedures demonstrated included robotic-assisted surgeries for prostate and kidney conditions, as well as transplant techniques. Sessions also explored the integration of artificial intelligence in surgical planning and the potential of telesurgery. It is indicated that a parallel workshop was also conducted for nurses and technicians focused on robotic surgery competencies and case-based learning. The event emphasized live procedures, hands-on learning, and multidisciplinary collaboration, leveraging advanced platforms like the da Vinci system to strengthen India's growing robotic urology ecosystem. The conference was inaugurated by Member of Parliament (Pali), PP Chaudhary, in the presence of Dr. GD Puri, Executive Director, AIIMS Jodhpur.
The Hindu
05-07-2025
- Health
- The Hindu
OGH performs over 100 free paediatric kidney surgeries, including on infants as young as six months
The Department of Urology at government-run Osmania General Hospital (OGH) has successfully performed 109 paediatric kidney and urinary tract stone surgeries over the last one-and-a-half-year period, including on infants as young as six months. 'These are surgeries that most often push families into the corporate sector, where each procedure can cost over ₹1 lakh. But at OGH, we are now able to offer the same quality of care at no cost. It is remarkable to see such sophisticated procedures being safely performed even on babies under one year,' said S. Anand, Consultant Urologist, Osmania General Hospital. The hospital's paediatric urology programme has expanded rapidly over the past year, aided by infrastructure upgrades and the acquisition of advanced equipment such as paediatric endoscopes, lasers and laparoscopic tools. 'We are not only catching up with the private sector, we are making this care accessible to the poorest families,' Dr. Anand added. Among the advanced procedures carried out were Percutaneous Nephrolithotomy (PCNL), Retrograde Intrarenal Surgery (RIRS), and Ureteroscopic Lithotripsy (URSL), all of which are traditionally considered complex and high-risk in very young children. In a standout case, PCNL was successfully performed on a six-month-old baby who recently celebrated his first birthday, doctors said. According to hospital data, the paediatric cases were grouped into three age brackets, 0–5 years, 6–10 years, and 11–17 years and findings showed that minimally invasive stone removal procedures are safe and feasible even in the youngest cohort, provided appropriate instrumentation is used. Dr. Anand highlighted the importance of early diagnosis and intervention. 'With increasing awareness and access, we can prevent complications and long-term kidney damage in children. Our goal is to ensure that no child suffers just because they cannot afford treatment,' he said.
Yahoo
20-05-2025
- Health
- Yahoo
Biden's prostate cancer diagnosis prompts awareness for early screening
(WHTM) – According to the Pennsylvania Prostate Cancer Coalition, more than 13,000 Pennsylvanians will be diagnosed with prostate cancer in 2025, and nearly 1,500 will die. The coalition says only 33% of men ages 50+ keep up with routine screenings, and, unfortunately, it takes a well-known public figure like former president Joe Biden getting diagnosed to serve as a reminder. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Retired Col. James (Jim) Williams says a Prostate-Specific Antigen Test led to his prostate cancer diagnosis. 'This young doctor arbitrarily included in the blood work, something called PSA,' Williams says. Over 30 years later, he's cancer-free and Chairman of the Pennsylvania Prostate Cancer Coalition. Williams says Biden is a good example of why the digital rectal exam is important because that's how a small nodule was found in his prostate. Top Pennsylvania lawmakers took $119K in gifts, trips, and more from those seeking to influence them in 2024 'A physician can actually feel a portion of your prostate through the rectum more,' Williams says. 'It's a very uncomfortable 10-second test, but it could save your life.' Biden's personal office says the cancer spread to his bones. 'We are really no longer looking at a type of cancer that's necessarily curable, but it is highly treatable,' says Dr. Jay Raman, Chair of the Department of Urology at Penn State Health. Biden's cancer has a Gleason score of 9 on a scale of 6 to 10. 'High grade prostate cancer, like the Gleason 9, prostate cancer will grow rapidly and may spread quickly, so I'm not certainly implying that there was any sort of miss with regards to his diagnosis,' says Dr. Raman. 'At age 82, most guideline panels don't recommend routine screening for prostate cancer in men beyond 70 to 75 years of age.' Williams says routine screening is needed later in life. 'You need to go to the doctor when you're well, not when you're sick,' Williams says. 'Men take better care of their cars than they take care of their prostate.' Biden's office says that while the cancer is aggressive, it appears to be hormone-sensitive. 'President Biden is probably receiving treatment that reduces his testosterone levels, and that's starving the prostate cancer cells,' Dr. Raman says. Williams says the side effects of treatment will determine Biden's quality of life. Raman says Biden will likely have cancer for the rest of his life. 'I could very well foresee President Biden living for a number of more years on treatment without this impacting his life expectancy,' Raman says. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
